Valuation: Stryker Corporation

Market Cap 125B 2,188B 109B 101B 93.74B 178B 11,919B 181B 1,207B 469B 5,859B 470B 460B 20,189B P/E 2026 *
25.7x
P/E 2027 * 22.5x
Enterprise Value 134B 2,342B 117B 108B 100B 190B 12,760B 193B 1,293B 502B 6,272B 503B 492B 21,613B EV / Sales 2026 *
4.91x
EV / Sales 2027 * 4.42x
Free-Float
94.62%
Yield 2026 *
1.1%
Yield 2027 * 1.18%
1 day-5.52%
1 week+0.73%
Current month-5.52%
1 month+2.26%
3 months-6.83%
6 months-14.64%
Current year-14.64%
1 week 5,463
Extreme 5463
5,782
1 month 5,423.5
Extreme 5423.5
5,782
Current year 5,025
Extreme 5025
6,769.22
1 year 5,025
Extreme 5025
7,569.86
3 years 4,663.01
Extreme 4663.01
8,216
5 years 3,953.6
Extreme 3953.6
8,216
10 years 2,469
Extreme 2469
8,216
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
-5.52%+0.73% - - 125B
+0.04%-1.01%+1.39%-6.08% 12.77B
+7.83%+2.71%+43.32%+112.86% 8.71B
+2.29%+7.17%-46.92%-72.29% 4.07B
+4.16%+8.39%+25.37%+43.89% 2.73B
+2.53%+23.07%-7.66%-13.04% 1.89B
+3.55%+8.85%-0.99%-23.29% 1.67B
-5.25%-5.89%+179.33%+133.76% 1.46B
+3.28%+2.69%-63.46%-85.31% 1.35B
Average +1.43%+1.83%+16.30%+11.31% 4.33B
Weighted average by Cap. -3.72%+1.64%+12.53%+21.58%

Financials

2026 *2027 *
Net sales 27.27B 477B 23.84B 21.91B 20.42B 38.73B 2,596B 39.32B 263B 102B 1,276B 102B 100B 4,398B 29.58B 517B 25.86B 23.77B 22.15B 42.02B 2,817B 42.65B 285B 111B 1,385B 111B 109B 4,771B
Net income 4.84B 84.68B 4.24B 3.89B 3.63B 6.88B 461B 6.99B 46.73B 18.17B 227B 18.19B 17.8B 781B 5.54B 96.89B 4.85B 4.45B 4.15B 7.87B 528B 7.99B 53.47B 20.79B 259B 20.81B 20.36B 894B
Net Debt 8.83B 154B 7.72B 7.09B 6.61B 12.54B 840B 12.73B 85.14B 33.1B 413B 33.13B 32.42B 1,424B 5.47B 95.54B 4.78B 4.39B 4.09B 7.76B 520B 7.88B 52.72B 20.5B 256B 20.52B 20.08B 882B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-07-01 MX$5,463.00 -5.52% 163
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
326.54USD
Average target price
386.80USD
Spread / Average Target
+18.45%

Quarterly revenue - Rate of surprise